The Enterprise Value as of December 2025 (TTM) for CANbridge Pharmaceuticals Inc. (1228.HK) is 947.49M

According to CANbridge Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 947.49M. This represents a change of 445.56% compared to the average of 173.67M of the last 4 quarters.

CANbridge Pharmaceuticals Inc. (1228.HK) Historical Enterprise Value (quarterly & annually)

How has 1228.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of CANbridge Pharmaceuticals Inc. over the last ten years is 337.60M. The current 947.49M Enterprise Value has changed 27.97% with respect to the historical average. Over the past ten years (40 quarters), 1228.HK's Enterprise Value was at its highest in in the September 2020 quarter at 2.38B. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.

CANbridge Pharmaceuticals Inc. (1228.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of CANbridge Pharmaceuticals Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CANbridge Pharmaceuticals Inc. (1228.HK) Average Enterprise Value

How has 1228.HK Enterprise Value performed in the past?

The current Enterprise Value of CANbridge Pharmaceuticals Inc. (1228.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

CANbridge Pharmaceuticals Inc. (1228.HK) Enterprise Value vs. Peers

How is 1228.HK’s Enterprise Value compared to its peers?

CANbridge Pharmaceuticals Inc.’s Enterprise Value is greater than Kintor Pharmaceutical Limited (824.65M), greater than Uni-Bio Science Group Limited (617.31M), greater than Sirnaomics Ltd. (93.03M), less than China Biotech Services Holdings Limited (1.11B), greater than ClouDr Group Limited (816.06M), less than Wenzhou Kangning Hospital Co., Ltd. (1.64B), less than Hospital Corporation of China Limited (1.15B), less than Transcenta Holding Limited (1.21B), less than Beijing Biostar Pharms Co Ltd (0), greater than Suzhou Basecare Medical Corporation Limited (364.85M),

Build a custom stock screener for CANbridge Pharmaceuticals Inc. (1228.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CANbridge Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CANbridge Pharmaceuticals Inc. (1228.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CANbridge Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.